ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to Reach USD 92.92 Million by 2035 at 3.7% CAGR
DE, UNITED STATES, March 2, 2026 /EINPresswire.com/ -- The ESR1 Mutated Metastatic Breast Cancer Diagnostics Market stands at USD 64.61 million in 2025 and is projected to expand to USD 92.92 million by 2035, reflecting a steady compound annual …